RevBio, Inc.

?? RevBio, Inc. received regulatory and ethics approvals in multiple European countries to conduct a pivotal clinical trial for its TETRANITE? dental implant stabilization product, aiming for CE marking approval and commercial launch in Europe. ??Alan Pollack, RevBio’s Senior Director of Dental Clinical Operations, shared: “This clinical trial has the potential to significantly accelerate the timeframe when this promising bone adhesive technology can be used in the field of dentistry.” ?? Learn more: https://lnkd.in/dbuWBU_T ?? Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dVaEc9EA #MedicalDevices #MedicalEquipment #HealthTech #MedTechNews #Healthcarenews #Headhunter #Leadership #GuidedSolutions #ExecutiveSearch #Executive #MedTechExecutiveSearch

RevBio is pleased to announce it has received regulatory and ethics committee approvals in multiple European countries to conduct a pivotal clinical trial for our dental implant stabilization product.?We have currently enrolled 30 of an expected 75 patients in this clinical trial. “This breakthrough material promises to open a new chapter in dental care, redefining what is possible in regenerative dentistry,” said?Prof. Dr. med. Dent., Patrick Schmidlin, head of the Division of Periodontology at the University of Zurich and RevBio Clinical Investigator. Please click the link below to learn more about this key study necessary for product approval. https://shorturl.at/nF2Wz #RevBio #TETRANITE #BoneAdhesive #DentalImplants #ImplantStabilization #ClinicalTrial #RegenerativeMedicine #TransformingBoneRepair #TETRANITEit #ProductApproval #ImmediateFixation

We are just two weeks away from LSI USA ‘25 and CEO Brian Hess will be presenting on behalf of RevBio to a full house of investors and strategics in the medtech industry. Be sure to check out his presentation at 4:30pm PST on March 18th [Track 5] to learn more about TETRANITE, our novel platform biomaterial technology, and RevBio’s recent achievements–you won't want to miss it! #LSI #LSIUSA #LSIUSA25 #LifeSciences #RevBio #TETRANITE #TransformingBoneRepair #TETRANITEit #BoneAdhesive #PlatformTechnology #RegenerativeMedicine #medtech #healthtec #biomaterials #NovelTechnology

Clinicians who VC loves hearing directly from people who are building and scaling transformational companies. Last week’s fireside with Brian Hess, CEO of RevBio, Inc. was exactly that. ?? RevBio is transforming bone repair with a novel biocompatible bone adhesive that works in both bone-to-bone and bone-to-metal applications. Their test article has flown TWICE to the International Space Station National Laboratory on SpaceX rockets—a milestone few companies can claim. They’ve secured over $20 million in non-dilutive funding—a masterclass in how a startup can turn grants into a repeatable, scalable system. ?? They’re now in two first-in-human clinical trials, navigating regulatory pathways with remarkable efficiency. Scrub Capital is always looking for well-executed, regulatory-savvy medical device companies solving critical problems. If this is you—we want to hear from you. For anyone thinking about how to fund and scale medical device innovations, this was a blueprint in execution. ?? Watch the highlights below! If you’d like to join Clinicians Who VC, our rules are simple: ?? You have to be a clinician. ?? You have to be interested in investing—either now or in the future. ??Link to join the waitlist is in the comments below. Want to join us as a speaker? Drop a note to me, Rebecca Mitchell, MD, or Christina Farr Note/ Disclosure: I am a co-founder and on the scientific advisory board of RevBio. Scrub Capital venture partner Kevin Foley, M.D. is RevBio’s chief medical officer.

Just 35 days to go until #LSIUSA25! We’re thrilled to announce that our CEO, Brian Hess, will be part of a dynamic panel discussion titled?"Beyond Robotics: What's Shaping the Future in Orthopaedics?"? He’ll be joining leading innovators and industry experts in the Medtech and Healthtech space to explore the trends and breakthroughs that are driving the future of orthopaedics. Have you registered for #LSIUSA25 yet? If so, be sure to mark your calendars for March 19th at 10:10 AM (Track 1) for this engaging and insightful panel–it's one you won’t want to miss! To learn more about #LSIUSA25 and secure your spot, visit:?https://lnkd.in/dw_teTUK

The countdown to LSI USA '25 is officially on! We are excited to share that CEO Brian Hess will be participating in a panel at this year's conference, "Beyond Robotics, What's Shaping the Future in Orthopaedics?" Stay tuned for more details. For more information on LSI USA, visit: https://lnkd.in/gS2KF_wr #RevBio #TETRANITE #LSI #LSIUSA25 #lifesciences #TETRANITEit #TransformingBoneRepair #Orthopaedics #FractureRepair #BoneAdhesive #RegenerativeMedicine

?? #MedTech updates week 5 - 2025 ?? ?? Funding Successes: Nobi Smart Lights: Secured €35M to advance its AI-powered fall detection technology, to improve elderly care via smart monitoring. Roeland Pelgrims Amplitude Vascular Systems: Raised $36M to support the US launch of its Pulse IVL device, a breakthrough in intravascular lithotripsy. Mark Toland Allara: Secured $26M to expand its women’s hormonal telehealth services, improving accessibility to specialized care. Rachel Blank. Neuronoff, Inc.: Secured $5M to advance its minimally invasive neuromodulation platform, targeting new treatments for neurological conditions. Manfred Franke NeuroBionics: Secured an oversubscribed $5M seed round to advance endovascular neuromodulation technology, pushing new frontiers in non-invasive brain treatments. MJ Antonini PhotoniCare, Inc.: Collected $4.6M in Series B funding to advance its middle ear imaging technology, to improve the diagnosis of ear infections. Cary Vance ?? Regulatory Approvals & Key Patents RevBio, Inc.: Issued a key patent for its regenerative bone adhesive technology, paving the way for new advancements in orthobiologics. Brian Hess SyntheticMR: Received regulatory clearance in Japan for its SyMRI 3D imaging solution, further strengthening its global footprint in medical imaging. Ulrik Harrysson Imperative Care: Received FDA 510(k) clearance for its stroke thrombectomy system, enhancing life-saving stroke treatment options. Fred Khosravi NeurAxis: Secured FDA clearance for its self-inflating balloon device RED, a breakthrough in digital health and minimally invasive treatment. Brian Carrico Flex-Z? SpinePoint Cages: Successfully passed mechanical testing, clearing the way for FDA submission within months, targeting approval by mid-year. Lali Sekhon, Caranx Medical: Submitted its AI-powered TAVI/TAVR guide software to FDA, marking a major step forward in precision cardiology. J?rgen Bundgaard Hansen Stereotaxis: Won European approval for its robotic ablation catheter, revolutionizing precision electrophysiology treatments. David Leo Fischel Instylla: Received FDA clearance for its Tembo Embolic System, advancing minimally invasive vascular care. Amar Sawhney Vantis Vascular: Announced the 1st commercial use of its microcatheter delivery system Jason Turner ?? Strategic Collaborations & Mergers Inogen & Yuwell Global: Formed a strategic collaboration to expand their global product portfolio in oxygen therapy & respiratory care. Nabil Shabshab, Zimmer Biomet: Announced a definitive agreement to acquire Paragon28 strengthening its position in orthopedics and foot & ankle solutions. Ivan Tornos Stryker selling its spine implant business to Viscogliosi Bros., LLC This move confirms Stryker’s shift toward higher-growth areas while Viscogliosi leverages its industry experience to expand its portfolio. Marc Viscogliosi #Innovation #Funding #RegulatoryApprovals Guided Solutions GS Capital Connect

We’re thrilled to have RevBio, Inc.’s Founder & CEO, Brian Hess, as the 2025 M2D2 $200K Challenge Keynote Presentation! He’ll share firsthand insights on navigating the FDA approval process—including the do’s and don’ts?every medtech startup needs to know. Brian knows the journey well. RevBio, a 2023 $200K Challenge winner, has just secured its 10th patent?for TETRANITE?, a groundbreaking bone adhesive designed for bone regeneration. And their momentum keeps building—they recently gained FDA approval, a game-changing milestone! Your startup could be next. Apply to the 2025 $200K Challenge?and take the first step toward turning your innovation into success—just like RevBio did! Submit your application today:?https://lnkd.in/e73wi-ZJ

RevBio is proud to announce the issuance of the 10th?patent for TETRANITE. This key patent will significantly expand our patent protected novel technology platform. “The granting of this patent continues to expand RevBio's controlling intellectual property estate in the mineral-organic bone adhesive space,” said George W. Kay, DMD, MMSc, Chief Scientific Officer and co-founder of RevBio, Inc. TETRANITE is a patented bone adhesive which includes phosphoserine, an organic compound, which has been shown in published literature to play a role in the process of bone regeneration. For more information on this significant milestone, please read the full press release below. #RevBio #TETRANITE #TransformingBoneRepair #TETRANITEit #RegenerativeMedicine #BoneAdhesive #IP #USPTO #PatentProtected #NovelProduct #PlatformTechnology USPTO

The RevBio?dental?team was delighted to?welcome Dr. Michael Norton?from the UK,?a renowned?oral surgeon and RevBio clinical advisor and research investigator. Throughout the day, Dr. Norton provided?valuable insights following extensive user handling trials of RevBio’s dental products, including the?formulation testing for?TETRANITE Implant Stabilization Material and our?Dental Adhesive Bone Scaffold. He also had the opportunity to experience product demonstrations for other TETRANITE applications, such as our orthopedic and cranial flap formulations. We are deeply grateful for Dr. Norton’s ongoing dedication and expertise,?as well as his participation as an investigator in ongoing RevBio clinical trials,?which continue to drive the advancement of RevBio's?innovative regenerative adhesive biomaterial. #RevBio #TETRANITE #biomaterial #TETRANITEit #TransformingBoneRepair #BoneAdhesive #RegenerativeMedicine #dental #implantstabilization #DentalBoneScaffold #ClincalInvestigator #ClincalTrials #ProductFormulation #PlatformTechnology Norton Implants